MbrlCatalogueTitleDetail

Do you wish to reserve the book?
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
Journal Article

HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

2023
Request Book From Autostore and Choose the Collection Method
Overview
目的:我们进行这项研究以确定与1型糖尿病(T1D)中人类白细胞抗原(HLA)‐DR3/DQ2介导的谷氨酸脱羧酶(GAD65)特异性CD4 T细胞激活可能相关的致糖尿病性GAD65肽。 方法:选取与HLA‐DR3/DQ2分子在体外结合强烈的前30个GAD65肽, 分为4个池组。使用这些肽来刺激研究对象的CD4 T细胞, 在16小时PBMC培养中分析CD4 T细胞对干扰素(IFN‐γ), 白介素(IL)‐17, 肿瘤坏死因子‐α(TNF‐α)和IL‐10的激活表达, 使用流式细胞术进行分析。 结果:所有四个GAD65肽池(PP1‐4)都导致CD4 T细胞的IFN‐γ表达明显增加(p=0.003, p<0.0001, p=0.026 和 p=0.002, 分别), 只有池2在T1D患者与健康对照组之间显示出显著的IL‐17表达增加(p<0.0001)。肽间组间比较显示, 在患者中, PP2组与其他组相比, IFN‐γ和IL‐17的表达显著增加, IL‐10的表达显著降低(p<0.0001, p=0.02 和 p=0.04), 但在对照组中没有显示出明显差异。此外, 2号组肽对于HLA‐DRB1 * 03‐DQA1 * 05‐DQB1 * 02 + 患者而言, 导致CD4 T细胞的IFN‐γ和IL‐17表达显著增加(p=0.002), 而IL‐10表达显著降低(p=0.04)。在HLA‐DRB1 * 03‐DQA1 * 05‐DQB1 * 02 +的最近诊断的T1D患者中, CD4 T细胞的IL‐17表达显著增加(p=0.03)。 结论:GAD65肽, 尤其是属于PP2的肽段, 在T1D患者中能够诱导CD4 T细胞表达IFN‐γ和IL‐17细胞因子, 这表明在患者中2号组肽可能通过HLA‐DR3分子递呈给CD4 T细胞, 使免疫平衡朝向炎症表型转变。
Publisher
John Wiley & Sons, Inc,Wiley Publishing Asia Pty Ltd